Literature DB >> 13757211

Measurement of the protective effect of attenuated poliovirus vaccine.

J KNOWELDEN, J H HALE, P S GARDNER, L H LEE.   

Abstract

Entities:  

Keywords:  POLIOMYELITIS/immunology

Mesh：

Substances：

Year:  1961        PMID： 13757211      PMCID： PMC1953940          DOI： 10.1136/bmj.1.5237.1418

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  1 in total

1.  Large-scale use of Sabin type 2 attenuated poliovirus vaccine in Singapore during a type 1 poliomyelitis epidemic.

Authors:  J H HALE; M DORAISINGHAM; K KANAGARATNAM; K W LEONG; E S MONTEIRO
Journal:  Br Med J       Date:  1959-06-20
  1 in total
  5 in total

1.  [USE OF HOMOTYPIC ORAL ANTIPOLIOMYELITS VACCINATION IN AN EPIDEMIC CAUSED BY TYPE I POLIOMYELITIS VIRUS IN FRANCE].

Authors:  R DEBRE; G COULON; G LEDOURNEUF; M GAUTIER; J CELERS; V DROUHET; A BOUE
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

2.  Immune status of the population to poliovirus infection in Singapore.

Authors:  K T Goh; S Yamazaki
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

3.  For and against smallpox vaccination.

Authors: 
Journal:  Br Med J       Date:  1970-05-09

4.  [Attempt to interpret some cases and research during a type I poliomyelitis epidemic having given rise to a vaccination campaign by homotypic live vaccine].

Authors:  R Debré; J Celers; V Drouhet; A Boué; R Netter
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

5.  Control of a type 1 poliomyelitis epidemic in British Guiana, 1962-63, with trivalent oral poliovirus vaccine. 1. Epidemiological aspects.

Authors:  J J Witte; M I Page; H M Gelfand
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.